Remove 2020 Remove Competition Remove Leads
article thumbnail

Pharma is big business whose goal is to maximize shareholder value

World of DTC Marketing

From 2016 to 2020, the 14 leading drug companies spent $577 billion on stock buybacks and dividends—$56 billion more than they spent on R&D over the same period.” ” From 2016 to 2020, compensation for the 14 companies’ top executives totaled $3.2 Big pharma is big business.

Pharma 292
article thumbnail

Pharma’s reputational high will be short-lived

World of DTC Marketing

Pharma has gone to court again and again to delay generic competition of biologic drugs. One company AbbVie has used the courts to stop competition of its top drug Humira. By the look of 2020’s results, he’s on the right track—and his compensation shows it. For writing that 2020 success story, CEO Albert Bourla, Ph.D.,

Pharma 186
article thumbnail

Episode 28 – A CEO Leading a MedTech Company Through Covid

Medical Device Success

Reading time: 2 – 3 minutes In January 2018 when Dominik Beck took the helm of Rudolf Riester, GmbH, he began executing a plan to put Riester in a more competitive position against its larger rivals. Then in early 2020 Covid spread across the world. Then in early 2020 Covid spread across the world.

Leads 100
article thumbnail

8 Ways to Enhance the Patient Experience & Drive Leads with QR Codes

Healthcare Success

Ready to start leveraging QR code technology and stay ahead of your competition? In this blog post, you’ll learn: Why QR codes have made a comeback, When to use them, And, 8 ways to improve the patient experience and drive leads with QR codes. . consumers at the beginning of 2020, when the COVID-19 pandemic hit. households.

Leads 113
article thumbnail

2020 Sales Hiring Forecast

Sales Talent

By comparing these forecasts to historical data, we developed our 2020 sales hiring forecast. This pressure is leading to increased base salaries. 2020 Sales Hiring Forecast. Sales hiring in 2020 shows no signs of slowing down. Manpower forecasts a Q1 2020 Net Employment Outlook for the U.S. 4 percent in 2020.

Sales 52
article thumbnail

Eli Lilly places price cap of $35 on out-of-pocket insulin cost

Pharmaceutical Technology

These two insulin therapies have been off patent for about a decade but have a list price of about $500 for a pack of five injection pens and currently have limited competition from biosimilars. At $92 for a five-pack of injections, Rezvoglar is a 78% discount on the price of Lantus.

article thumbnail

Top biopharmaceutical Covid-19 vaccine companies boosted with over 80% revenue growth

Pharmaceutical Technology

The top 13 players reported more than 10% revenue growth, with BioNTech (3,834.4%), Moderna (2,199.1%), Pfizer (95.2%) and Regeneron Pharmaceuticals (89.1%) reporting a more than 80% year-on-year (YoY) revenue growth from 2020 to 2021, according to GlobalData’s Pharma Intelligence Centre Companies Database. AbbVie reported a 22.7%

Sales 108